🇺🇸 FDA
Patent

US 9096608

Pharmaceutically active pyrazolo-triazine derivatives

granted A61PA61P29/00A61P31/00

Quick answer

US patent 9096608 (Pharmaceutically active pyrazolo-triazine derivatives) held by Lead Discovery Center GmbH expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Lead Discovery Center GmbH
Grant date
Tue Aug 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61P, A61P29/00, A61P31/00, A61P35/00, A61P9/00